Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma

View at publisher
Authors: Yun‐Hsin Tang, Cheng-Lung Hsu, Angel Chao, Chyong‐Huey Lai, Shih-Ming Jung, Yun-Shien Lee, Ying-Chih Chang, Chiao‐Yun Lin
Cited by: 1
References: 31

Fields of Study & Subjects

PI3K/AKT/mTOR signaling in cancer Advanced Breast Cancer Therapies Endometrial and Cervical Cancer Treatments

Publication details

Journal / source
Cancer Gene Therapy
Publisher
Springer Science and Business Media LLC
Volume
33
Issue
5
Pages
588–600
Publication date
1 May 2026
Language
EN